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Abstract
Development of cardiac dysfunction is associated with increased morbidity and mortality in patients with sepsis. Increasing
evidence shows that gender determines the degree of inflammatory response of the host and that females tolerate sepsis
better than males. It is unknown whether gender affects the cardiac dysfunction in animals or patients with sepsis. To
investigate this, male or female C57BL/6 mice were subjected to either lipopolysaccharide (LPS)/peptidoglycan (PepG) co-
administration or cecal ligation and puncture (CLP). At 18 hours after LPS/PepG injection or 24 hours after CLP, cardiac
function was evaluated by echocardiography. The septic insult caused a significant cardiac dysfunction in both genders.
However, the cardiac dysfunction was significantly less pronounced in females in comparison with males subjected to LPS
(3 mg/kg)/PepG (0.1 mg/kg) or CLP. Compared with males injected with LPS (3 mg/kg)/PepG (0.1 mg/kg), western blotting
analysis of the myocardium from females injected with LPS/PepG revealed i) profound increases in phosphorylation of Akt
and eNOS; ii) significant decreases in phosphorylation of IkBa, nuclear translocation of the NF-kB subunit p65, decreased
expression of iNOS and decreased synthesis of TNF-a and IL-6 in the heart. However, the gender dimorphism of the cardiac
dysfunction secondary to LPS/PepG was not observed when higher doses of LPS (9 mg/kg)/PepG (1 mg/kg) were used. In
conclusion, the cardiac dysfunction caused by sepsis was less pronounced in female than in male mice. The protection of
female hearts against the dysfunction associated with sepsis is (at least in part) attributable to cardiac activation of the Akt/
eNOS survival pathway, decreased activation of NF-kB, and decreased expression of iNOS, TNF-a and IL-6. It should be noted
that the observed gender dimorphism of the cardiac dysfunction in sepsis was not seen when a very severe stimulus (high
dose of LPS/PepG co-administration) was used to cause cardiac dysfunction.
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Introduction
Sepsis is one of the most common causes of morbidity and
mortality among admissions to the intensive care unit [1,2]. Sepsis
is a systemic dysregulated hyperinflammatory and/or anti-
inflammatory response to infectious stimuli, such as bacteria,
viruses and fungi, which, when excessive, may progress to organ
failure and death [3]. Development of myocardial dysfunction is
associated with increased morbidity and mortality of sepsis. More
than 40% cases of sepsis have cardiovascular impairment [4] and
the presence of myocardial dysfunction can increase the mortality
rate of affected patients to 70% [5].
There is now good evidence that gender is a key determinant in
the degree of the host inflammatory response and even of outcome
in patients with sepsis. In a number of clinical and epidemiological
studies, a significantly increased survival rate was reported in
female patients when compared with male patients with sepsis [6–
9]. This may be associated with lower pro-inflammatory and
higher anti-inflammatory cytokine levels in female patients [9].
Moreover, healthy female volunteers challenged with either
lipopolysaccharide (LPS) or lipoteichoic acid (LTA) showed less
pro-inflammatory response than males as demonstrated by lower
levels of tumor necrosis factor (TNF)-a, interleukin (IL)-1b, IL-6
and IL-8 in blood [10]. In addition, severely injured male trauma-
patients had a higher incidence of sepsis, multiple organ
dysfunction syndrome and greater elevations in plasma procalci-
tonin and IL-6 compared with the equivalent group of females
[11]. Further basic research studies also confirmed these clinical
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data on gender dimorphism following sepsis. These experimental
studies suggested that females had immunologic advantage and
showed a significantly increased survival rate compared with males
following induction of polymicrobial sepsis by cecal ligation and
puncture (CLP) [12]. In addition, estrogen treatment attenuated
the liver dysfunction and intestine injury caused by sepsis in rats
with decreased serum aspartate aminotransferase (AST), alanine
aminotransferase (ALT) levels and ameliorated oxidative organ
damage [13], while testosterone receptor blockade with flutamide
following trauma-hemorrhage restored immune depression and
significantly decreased the mortality after a subsequent septic
challenge in male animals [14].
However, little is known about the impact of gender dimor-
phism on cardiac dysfunction caused by sepsis. Moreover, the
mechanisms underlying the gender difference in susceptibility of
the heart to a septic challenge are not understood. The present
study was designed to determine whether the severity of
myocardial dysfunction caused by either co-administration of
LPS/peptidoglycan (PepG) or polymicrobial sepsis induced by
CLP differs in male and female mice. Having found that the
cardiac dysfunction associated with sepsis was less pronounced in
female than in male mice, we have then investigated the potential
signalling pathways that may have contributed to the observed
differences.
Materials and Methods
Animals
The animal protocols followed in this study were approved by
the Animal Welfare Ethics Review Board (AWERB) of Queen
Mary University of London in accordance with the derivatives of
both the Home Office guidance on the Operation of Animals
(Scientific Procedures Act 1986) published by Her Majesty’s
Stationery Office and the Guide for the Care and Use of
Laboratory Animals of the National Research Council. All surgery
was performed under ketamine/xylazine anesthesia and echocar-
diography was performed under inhalation anesthesia of isoflur-
ane, buprenorphine was administered before surgery as well as 6
hours and 18 hours after surgery to reduce postoperative pain, and
all efforts were made to minimize suffering of the animals. This
study was carried out on ten week-old male (n = 29) and age-
matched female (n = 22) C57BL/6 mice, weighing 20–30 g, and
eight month-old male (n = 12) and age-matched female (n = 12)
C57BL/6 mice (Charles River Laboratories UK Ltd., Kent, UK),
weighing 35–50 g. The animals were allowed to acclimatize to
laboratory conditions for a period of at least one week before any
experimental procedures were initiated. They were housed in
individually ventilated cages lined with an absorbent bedding
material with no more than 6 mice per cage. The room
temperature and humidity was maintained at 19uC–23uC and
55%, respectively. All animals had free access to a standard diet
and water ad libitum. The feeding boxes were cleaned and
disinfected every 3 days, and the water was changed on a daily
basis to prevent infectious diseases. Animals were inspected for
signs of illness and/or unusual behaviour by research staff at least
once per day. All studies involving animals are reported in
accordance with the ARRIVE guidelines for reporting experi-
ments involving animals [15,16].
Model of LPS/PepG-induced Cardiac Dysfunction
Ten week-old male and female C57BL/6 mice received
intraperitoneal administration of LPS/PepG (LPS; 3 mg/kg and
PepG; 0.1 mg/kg or LPS; 9 mg/kg and PepG; 1 mg/kg in PBS;
5 ml/kg i.p.). Sham-treated mice were not subjected to LPS/
PepG, but were otherwise treated the same way. Eighteen hours
after LPS/PepG administration, cardiac function was assessed by
echocardiography in vivo. Mice were then deeply anesthetized i.p.
with ketamine/xylazine, and were killed by removing the hearts.
Heart samples were stored at 280uC for further analyses. Mice
were randomly allocated into eight different groups. The following
groups were studied for the low dose LPS/PepG co-administration
[LPS (3 mg/kg)/PepG (0.1 mg/kg)] study: (i) Male+vehicle
(n = 6); (ii) Female+vehicle (n = 4); (iii) Male+LPS/PepG (n= 7);
(iv) Female+LPS/PepG (n= 8). The following groups were studied
for the high dose LPS/PepG co-administration [LPS (9 mg/kg)/
PepG (1 mg/kg)] study: (i) Male+vehicle (n = 5); (ii) Female+
vehicle (n = 4); (iii) Male+LPS/PepG (n= 11); (iv) Female+LPS/
PepG (n= 6).
Model of Polymicrobial Sepsis caused by Cecal Ligation
and Puncture
Eight month-old male and female C57BL/6 mice were
subjected to CLP. Sham-operated mice were not subjected to
ligation or perforation of cecum but were otherwise treated the
same way. We followed the original CLP protocol introduced by
Wichterman and co-workers [17] with slight modifications
including analgesia, antibiotic therapy and fluid resuscitation as
described previously [18,19]. Based on previous evidence and
preliminary data, an 18-G needle was used with the double
puncture technique in order to generate reproducible cardiac
dysfunction during the early phase of sepsis (24 hours). Briefly,
mice were anesthetized i.p. with ketamine (100 mg/kg) and
xylazine (10 mg/kg) prepared in the same solution by using
1.5 ml/kg. Buprenorphine (0.05 mg/kg i.p.) was injected addi-
tionally to provide adequate analgesia. The rectal temperature of
the animals was maintained at 37uC with a homeothermic blanket.
The abdomen was opened via a 1.5 cm midline incision, and the
cecum exposed. The cecum was ligated just below the ileocecal
valve and punctured at both opposite ends. After a small amount
of fecal matter was extruded from both ends, the cecum was
placed back in its anatomical position and the abdomen was
sutured. Ringer’s solution was given s.c. for resuscitation directly
after surgery (1 ml/mouse) and 6 hours and 18 hours after surgery
(0.5 ml/mouse). Antibiotic (Imipenem/Cilastin; 20 mg/kg s.c.)
and analgesia (buprenorphine; 0.05 mg/kg i.p.) was administered
6 hours and 18 hours after surgery. At 24 hours after CLP, cardiac
function was assessed by echocardiography in vivo. Mice were then
deeply anesthetized i.p. with ketamine/xylazine, and were killed
by removing the hearts. Heart samples were stored at 280uC for
further analyses. Mice were randomly allocated into four different
groups: (i) Male+sham-operation (n= 4); (ii) Female+sham-opera-
tion (n= 4); (iii) Male+CLP (n= 8); (iv) Female+CLP (n= 8).
Assessment of Cardiac Function in vivo
Cardiac function was assessed in mice by echocardiography
in vivo as reported previously [18,19]. At 18 hours after LPS/PepG
co-administration or 24 hours after CLP, anesthesia was induced
with 3% isoflurane and maintained at 0.5 to 0.7% for the duration
of the procedure. Before assessment of cardiac function, mice were
allowed to stabilize for at least 10 minutes. During echocardiog-
raphy the heart rate was obtained from ECG tracing and the
temperature was monitored with a rectal thermometer. Two-
dimensional and M-mode echocardiography images were record-
ed using a Vevo-770 imaging system (VisualSonics, Toronto,
Ontario, Canada). Percentage fractional area change (FAC) was
assessed from a two-dimensional trace and percentage EF and
fractional shortening (FS) were calculated from the M-mode
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measurements in the parasternal short axis view at the level of the
papillary muscles.
Western Blot Analysis
Semi-quantitative western blot analyses were carried out in
mouse heart tissues as described previously [20]. We assessed the
degree of phosphorylation of Akt on Ser473, endothelial nitric
oxide synthase (eNOS) on Ser1177, inhibitor of kB (IkB) a on
Ser32/36, as well as the nuclear translocation of the p65 subunit of
nuclear factor (NF)-kB (nucleus/cytosol ratio) and inducible nitric
oxide synthase (iNOS) expression. Briefly, mouse heart samples
were homogenized in 10% homogenization buffer and centrifuged
at 4000 RPM for 5 minutes at 4uC. Supernatants were removed
and centrifuged at 14 000 RPM at 4uC for 40 minutes to obtain
the cytosolic fraction. The pelleted nuclei were re-suspended in
extraction buffer and centrifuged at 14 000 RPM for 20 minutes
at 4uC. The resulting supernatants containing nuclear proteins
were carefully removed, and protein content was determined on
both nuclear and cytosolic extracts using a bicinchoninic acid
(BCA) protein assay following the manufacturer’s directions
(Therma Fisher Scientific, Rockford, IL). Proteins were separated
by 8% sodium dodecyl sulphatepolyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to a polyvinyldenedifluoride (PVDF)
membrane, which was then incubated with a primary antibody
(rabbit anti-total Akt, dilution 1:1000; mouse anti-pAkt Ser473,
dilution 1:1000; rabbit anti-total eNOS, dilution 1:200; goat anti-
peNOS Ser1177, dilution 1:200; mouse anti-total IkBa, dilution
1:1000; mouse anti-IkBa pSer32/36, dilution 1:1000; rabbit anti-
NF-kB p65, dilution 1:1000; rabbit anti-total iNOS, dilution
1:200). Blots were then incubated with a secondary antibody
conjugated with horseradish peroxidase (dilution 1:10000) for 30
minutes at room temperature and developed with the ECL
detection system. The immunoreactive bands were visualized by
autoradiography. Densitometric analysis of the bands was
performed using the Gel Pro Analyzer 4.5, 2000 software (Media
Cybernetics, Silver Spring, MD, USA). Each group was then
adjusted against corresponding sham data to establish relative
protein expression when compared with sham animals.
Quantitative Determination of Tissue TNF-a and IL-6 by
ELISA
The expressions of TNF-a and IL-6 in mouse heart samples
were determined using mouse TNF-a and IL-6 immunoassay kits
(R&D Systems, Minneapolis, MN), respectively, and have been
normalized to the protein content.
Statistics
All values described in the text and figures are presented as
mean 6 standard error of the mean (SEM) of n observations,
where n represents the number of animals studied. Statistical
analysis was performed using GraphPad Prism 6.0 (GraphPad
Software, San Diego, California, USA). Two-way ANOVA
followed by Sidak’s multiple comparisons test was used to compare
intergroup differences. Comparing results were considered statis-
tically significant when P,0.05.
Materials
Unless otherwise stated, all compounds in this study were
purchased from Sigma-Aldrich Company Ltd (Poole, Dorset,
UK). All solutions were prepared using non-pyrogenic saline
[0.9% (w/v) NaCl; Baxter Healthcare Ltd, Thetford, Norfolk,
UK]. Antibodies for immunoblot analysis were purchased from
Santa Cruz Biotechnology, Inc. (Heidelberg, Germany).
Results
Gender Dimorphism of Cardiac Dysfunction in Response
to LPS (3 mg/kg)/PepG (0.1 mg/kg) Co-administration
To determine the gender difference of cardiac dysfunction
caused by LPS/PepG, left ventricular function was assessed using
echocardiography at 18 hours after intraperitoneal injection of
LPS (3 mg/kg)/PepG (0.1 mg/kg) or PBS (5 mg/kg). Mice
injected with LPS/PepG had a lower body temperature and a
lower heart rate in comparison to sham-treated mice (male sham/
female sham versus male+LPS/PepG/female+LPS/PepG; P,
0.05; Table 1). In sham-treated mice, there was no difference of
EF, FS or FAC between male and female mice (P.0.05;
Figure 1A–D). When compared to sham-treated mice, LPS/PepG
caused a significant reduction in EF (P,0.05; Figure 1A–B), FS
(P,0.05; Figure 1A, 1C) and FAC (P,0.05; Figure 1A, 1D) in
both male and female mice, indicating the development of cardiac
dysfunction in vivo. However, female mice subjected to LPS/PepG
exhibited significantly higher EF, FS and FAC in comparison with
male mice (P,0.05; Figure 1A–D), indicating the cardiac
dysfunction caused by LPS/PepG was less pronounced in female
than in male animals.
Gender Dimorphism of Cardiac Dysfunction in Response
to CLP-induced Polymicrobial Sepsis
The murine model of CLP with fluid resuscitation and
antibiotic treatment offers a clinically relevant model of abdominal
polymicrobial human sepsis. Cardiac dysfunction induced by
polymicrobial sepsis caused by CLP was only observed in 8
month-old male mice [19]. We sought to confirm the above
observed gender difference of cardiac dysfunction in the CLP
animal model in 8 month-old male and female mice. Left
ventricular function was assessed using echocardiography at 24
hours after CLP or sham surgery. Mice that underwent CLP had a
lower body temperature and a lower heart rate in comparison to
sham-operated mice (male sham/female sham versus male+CLP/
female+CLP; P,0.05; Table 1). In sham-operated mice, there was
no difference of EF, FS or FAC between male and female mice
(P.0.05; Figure 1E–H). When compared to sham-treated mice,
polymicrobial sepsis induced by CLP caused a significant
reduction in EF (P,0.05; Figure 1E–F), FS (P,0.05; Figure 1E,
1G) and FAC (P,0.05; Figure 1E, 1H) in both male and female
mice, indicating the development of cardiac dysfunction in vivo.
However, female mice that underwent CLP exhibited significantly
higher EF, FS and FAC in comparison with male mice (P,0.05;
Figure 1E–H), indicating the cardiac dysfunction induced by CLP
was less pronounced in female than in male animals.
Gender Dimorphism of the Phosphorylation of Akt in the
Hearts of Mice Subjected to LPS (3 mg/kg)/PepG
(0.1 mg/kg) Co-administration
The potential underlying mechanisms behind the observed
gender dimorphism of cardiac dysfunction were investigated by
semi-quantitative western blot analysis of the mouse heart
subjected to LPS/PepG at 18 hours. When compared to male
sham-treated mice, female sham-treated mice showed a higher
degree of phosphorylation of Akt on Ser473 in heart tissue, but
these data were not significant (P.0.05; Figure 2A). Exposure of
male mice to LPS/PepG for 18 hours caused a small and non-
significant increase in the phosphorylation of Akt on Ser473 (P.
0.05; Figure 2A). However, exposure of female mice to LPS/PepG
for 18 hours induced a significant increase in the phosphorylation
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Figure 1. Gender dimorphism of cardiac dysfunction in mice subjected to LPS (3 mg/kg)/PepG (0.1 mg/kg) co-administration and in
mice that underwent CLP. Panel A–D: Male or female mice received either LPS (3 mg/kg)/PepG (0.1 mg/kg) or PBS intraperitoneally. Cardiac
function was assessed at 18 hours. (A) Representative M-mode echocardiograms; percentage (%) (B) ejection fraction (EF); (C) fractional shortening
(FS); and (D) fractional area of change (FAC). The following groups were studied: Male+vehicle (n = 6); Female+vehicle (n = 4); Male+LPS/PepG (n= 7);
Female+LPS/PepG (n= 8). Panel E–H: Male or female mice were subjected to CLP or sham-operation. Cardiac function was assessed at 24 hours. (E)
Representative M-mode echocardiograms; % (F) EF; (G) FS; and (H) FAC. The following groups were studied: Male+sham-operation (n = 4); Female+
Gender, Cardiac Dysfunction and Sepsis
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of Akt on Ser473 compared with either female sham-treated mice
or male LPS/PepG-treated mice (P,0.05; Figure 2A).
Gender Dimorphism of the Phosphorylation of eNOS in
the Hearts of Mice Subjected to LPS (3 mg/kg)/PepG
(0.1 mg/kg) Co-administration
When compared to male sham-treated mice, female sham-
treated mice showed a higher degree of phosphorylation of eNOS
on Ser1177 in heart tissue, but these data were not significant (P.
0.05; Figure 2B). Exposure of male mice to LPS/PepG for 18
hours caused a small and not significant increase in the
phosphorylation of eNOS on Ser1177 (P.0.05; Figure 2B).
However, exposure of female mice to LPS/PepG for 18 hours
induced a significant increase in the phosphorylation of eNOS on
Ser1177 compared with either female sham-treated mice or male
LPS/PepG-treated mice (P,0.05; Figure 2B).
Gender Dimorphism of the Phosphorylation of IkBa in
the Hearts of Mice Subjected to LPS (3 mg/kg)/PepG
(0.1 mg/kg) Co-administration
In sham-treated mice, there was no difference in the phosphor-
ylation of IkBa on Ser32/36 between male and female hearts (P.
0.05; Figure 3A). When compared to sham-treated mice, both
male and female mice subjected to LPS/PepG demonstrated
significant increases in the phosphorylation of IkBa on Ser32/36 in
heart tissue (P,0.05; Figure 3A). However, the increase in IkBa
phosphorylation on Ser32/36 caused by LPS/PepG was signifi-
cantly less pronounced in hearts obtained from female than male
mice (P,0.05; Figure 3A).
Gender Dimorphism of Nuclear Translocation of the p65
NF-kB Subunit in the Hearts of Mice Subjected to LPS
(3 mg/kg)/PepG (0.1 mg/kg) Co-administration
In sham-treated mice, there was no difference of nuclear
translocation of the p65 NF-kB subunit between male and female
hearts (P.0.05; Figure 3B). When compared to sham-treated
mice, both male and female mice subjected to LPS/PepG
demonstrated significant increases in the nuclear translocation of
the p65 NF-kB subunit in heart tissue (P,0.05; Figure 3B).
However, female mice subjected to LPS/PepG exhibited a
significantly attenuated response in the nuclear translocation of
the p65 NF-kB subunit in comparison with male mice (P,0.05;
Figure 3B), indicating an important role of gender in LPS/PepG
induced activation of NF-kB.
Gender Dimorphism of the Expression of iNOS in the
Hearts of Mice Subjected to LPS (3 mg/kg)/PepG
(0.1 mg/kg) Co-administration
In sham-treated mice, we detected a faint expression of iNOS
protein, but there was no difference of iNOS expression between
male and female hearts (P.0.05; Figure 3C). When compared to
sham-treated mice, LPS/PepG caused significant increases in the
expression of iNOS protein in the heart (P,0.05; Figure 3C).
However, in hearts from female mice subjected to LPS/PepG, the
levels of iNOS protein were significantly lower than in hearts from
male mice subjected to LPS/PepG (P,0.05; Figure 3C).
sham-operation (n = 4); Male+CLP (n = 8); Female+CLP (n = 8). Panel A–H: Data are expressed as means 6 SEM for n number of observations. wP,
0.05 versus the respective sham group, #P,0.05 versus male LPS/PepG or CLP group.
doi:10.1371/journal.pone.0100631.g001
Table 1. Gender dimorphism of heart rate and temperature of mice responses to septic insults.
Parameter Male Female
Sham
LPS (3 mg/kg)/
PepG (0.1 mg/kg) Sham
LPS (3 mg/kg)/
PepG (0.1 mg/kg)
Number 6 7 4 8
Heart Rate (bpm) 543.33623.23 486.14615.07* 569.25616.44 505.75612.16*
Temperature (uC) 35.3860.31 30.3860.87* 35.6260.46 32.2460.94*
Sham CLP Sham CLP
Number 4 8 4 8
Heart Rate (bpm) 537.25625.76 481.13611.98* 546.75610.06 494.25618.69*
Temperature (uC) 35.0260.52 31.1960.67* 35.4560.32 32.0860.81*
Sham LPS (9 mg/kg)/
PepG (1 mg/kg)
Sham LPS (9 mg/kg)/
PepG (1 mg/kg)
Number 5 11 4 6
Heart Rate (bpm) 550.50626.34 456.72612.08* 570.75620.14 448.17628.53*
Temperature (uC) 35.5260.44 29.1660.63* 35.9060.48 29.7061.03*
Heart rate and temperature were recorded at 18 hours in mice subjected to LPS/PepG co-administration and at 24 hours in mice that underwent CLP. Bpm, beats per
minute. Data are expressed as means 6 SEM for n number of observations.
*P,0.05 versus the respective sham group,
#P,0.05 versus male LPS/PepG or CLP group.
doi:10.1371/journal.pone.0100631.t001
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Gender Dimorphism of the Expression of TNF-a and IL-6
in the Hearts of Mice Subjected to LPS (3 mg/kg)/PepG
(0.1 mg/kg) Co-administration
When compared to male sham-treated mice, female sham-
treated mice showed a lower TNF-a and IL-6 expressions in heart
tissue, but these data were not significant (P.0.05; Figure 3D–E).
When compared to sham-treated mice, both male and female
mice subjected to LPS/PepG demonstrated significant increases in
the expression of TNF-a and IL-6 in heart tissue (P,0.05;
Figure 3D–E). However, female mice subjected to LPS/PepG
exhibited a significantly attenuated response in the expression of
TNF-a and IL-6 in comparison with male mice after LPS/PepG
challenge (P,0.05; Figure 3D–E).
Gender Dimorphism of Cardiac Dysfunction was Blunted
in Response to High Dose of LPS (9 mg/kg)/PepG (1 mg/
kg) Co-administration
To further investigate whether the gender dimorphism still
exists under increased inflammatory stimulus, left ventricular
function was assessed using echocardiography at 18 hours after
intraperitoneal injection of LPS (9 mg/kg)/PepG (1 mg/kg) or
vehicle. Mice injected with LPS/PepG had a lower body
temperature and a lower heart rate in comparison to sham-
treated mice (male sham/female sham versus male+LPS/PepG/
female+LPS/PepG; P,0.05; Table 1). In sham-treated mice,
there was no difference in EF, FS or FAC between male and
female mice (P.0.05; Figure 4A–D). When compared to sham-
treated mice, LPS/PepG caused a significant reduction in EF (P,
0.05; Figure 4A–B), FS (P,0.05; Figure 4A, 4C) and FAC (P,
0.05; Figure 4A, 4D) in both male and female mice, indicating the
development of cardiac dysfunction in vivo. When compared to
male LPS/PepG-treated mice, female mice subjected to LPS/
PepG showed a significant increase in FAC (P,0.05; Figure 4A,
4D), but this was not significant for EF (P.0.05; Figure 4A–B) and
FS (P.0.05; Figure 4A, 4C), indicating that gender dimorphism of
the cardiac dysfunction after septic insult was abrogated by the
severe injury induced by high dose of LPS (9 mg/kg)/PepG
(1 mg/kg) co-administration.
Discussion
We describe here for the first time that the myocardial
dysfunction caused by LPS/PepG is less pronounced in female
than in male mice in vivo. This finding is in agreement with the
previous reports showing that the cardiac dysfunction caused by
myocardial ischemia/reperfusion injury [21], trauma-hemorrhage
[22] and burns [23] is also less pronounced in females than in
males. Estrogen modulates a number of acute injury-related
myocardial responses; specifically estrogen protects the heart
against the injury and dysfunction caused by trauma-hemorrhage
[24] and ischemia/reperfusion injury (in isolated hearts subjected
to global ischemia and in hearts undergoing LAD occlusion in vivo)
[25,26]. Although we provide clear evidence that female hearts
show less dysfunction than male murine hearts when challenged
with LPS/PepG, we wished to confirm this finding by using a
more clinically relevant model of polymicrobial sepsis with
antibiotic therapy and fluid-resuscitation caused by CLP in
middle-aged mice (8 month-old) [18,19]. The age of mice was
selected based on the knowledge that 8 month-old female C57BL/
6 mice are pre-ovarian failure and still have an active estrus cycle
[27]. Most notably, we demonstrate here that the cardiac function
in female mice subjected to polymicrobial sepsis induced by CLP
was significantly less pronounced than the cardiac dysfunction
Figure 2. Gender dimorphism of the phosphorylation of Akt and eNOS in the hearts of mice subjected to LPS (3 mg/kg)/PepG
(0.1 mg/kg) co-administration.Male or female mice received either LPS (3 mg/kg)/PepG (0.1 mg/kg) or PBS. Signalling events in heart tissue were
assessed at 18 hours. Densitometric analysis of the bands is expressed as relative optical density (O.D.) of (A) phosphorylated Akt (pSer473) corrected
for the corresponding total Akt content and normalized using the related sham band; (B) phosphorylated eNOS (pSer1177), corrected for the
corresponding total eNOS content and normalized using the related sham band. Each analysis (A–B) is from a single experiment and is representative
of three to four separate experiments. Data are expressed as means 6 SEM for n number of observations. wP,0.05 versus the respective sham
group, #P,0.05 versus male LPS/PepG group.
doi:10.1371/journal.pone.0100631.g002
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Figure 3. Gender dimorphism of the phosphorylation of IkBa, nuclear translocation of the p65 NF-kB subunit, expression of iNOS,
TNF-a and IL-6 in the hearts of mice subjected to LPS (3 mg/kg)/PepG (0.1 mg/kg) co-administration. Male or female mice received
either LPS (3 mg/kg)/PepG (0.1 mg/kg) or PBS. Signalling events in heart tissue were assessed at 18 hours. Densitometric analysis of the bands is
expressed as relative optical density (O.D.) of (A) phosphorylated IkBa (pSer32/36) corrected for the corresponding total IkBa content and normalized
using the related sham band; (B) NF-kB p65 subunit levels in both, cytosolic and nuclear fractions expressed as a nucleus/cytosol ratio normalized
using the related sham bands; (C) iNOS expression corrected for the corresponding tubulin band, and (D) TNF-a expression in heart tissue of mice
subjected to LPS/PepG; (E) IL-6 expression in heart tissue of mice subjected to LPS/PepG. Each analysis (A–E) is from a single experiment and is
representative of three to four separate experiments. Data are expressed as means 6 SEM for n number of observations. wP,0.05 versus the
respective sham group, #P,0.05 versus male LPS/PepG group.
doi:10.1371/journal.pone.0100631.g003
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observed in male mice. Taken together, these findings indicate
that the hearts of young or older female mice exhibit less cardiac
dysfunction in response to polymicrobial sepsis or co-administra-
tion of LPS/PepG.
To obtain a better insight into the mechanisms underlying the
observed gender dimorphism of the cardiac response to sepsis, we
investigated the phosphorylation of Akt, eNOS and IkBa, nuclear
translocation of NF-kB subunit p65, iNOS expression, as well as
TNF-a and IL-6 expression in murine hearts; When compared to
the hearts of male mice subjected to LPS/PepG, hearts of female
mice subjected to LPS/PepG showed i) profound increases in
phosphorylation of Akt and eNOS; ii) reductions in phosphory-
lation of IkBa and nuclear translocation of the NF-kB subunit
p65, iii) reduced expression of the pro-inflammatory cytokines
TNF-a and IL-6, and iv) reduced expression of iNOS.
Akt is a member of the phosphoinositide 3-kinases (PI3K) signal
transduction enzyme family, activation of which protects the heart
against injury [28,29]. Here we demonstrate that co-administra-
tion of LPS/PepG to female rather than male mice leads to a
greater increase in Akt-phosphorylation and, hence, activity in the
heart of female animals. Indeed, a greater increase in cardiac Akt
phosphorylation in female when compared to male hearts also
accounts for the reduced cardiac injury caused by ischemia-
reperfusion in female mice. Most notably, when the Akt-pathway
is blocked, the degree of cardiac injury in male and female mice
was identical. Thus, activation of cardiac Akt (presumably by
estradiol) protects female hearts against cardiac injury and
dysfunction [30]. Estradiol activates cardiac Akt, which in turn
also leads to a reduction in the cardiac dysfunction caused by
trauma-hemorrhage [24,29]. Blockade of the Akt pathway also
abrogated the salutary effects of estradiol on cardiac function
following trauma-hemorrhage [24]. Moreover, activation of Akt
mediates the inhibition by estradiol of the TNF-a expression and
NF-kB activation caused by LPS in cardiomyocytes [31]. In the
present study, we found a small increase in cardiac Akt activity in
female than in male sham hearts. In line with this finding, one
previous study showed that young women possess higher levels of
Akt in the myocardium compared to comparably aged men or
postmenopausal women, and that sexually mature female mice
have elevated Akt kinase activity in nuclear extracts of hearts than
male mice [32]. The hypothesis that cardiac Akt activity is
modulated by estrogen is also supported by the finding that the
Figure 4. Gender dimorphism of cardiac dysfunction was blunted in response to high dose of LPS (9 mg/kg)/PepG (1 mg/kg) co-
administration. Panel A–D: Male or female mice received either LPS (9 mg/kg)/PepG (1 mg/kg) or PBS intraperitoneally. Cardiac function was
assessed at 18 hours. (A) Representative M-mode echocardiograms; percentage (%) (B) ejection fraction (EF); (C) fractional shortening (FS); and (D)
fractional area of change (FAC). The following groups were studied: Male+vehicle (n = 5); Female+vehicle (n = 4); Male+LPS/PepG (n= 11); Female+
LPS/PepG (n= 6). Data are expressed as means 6 SEM for n number of observations. wP,0.05 versus the respective sham group, #P,0.05 versus
male LPS/PepG group.
doi:10.1371/journal.pone.0100631.g004
Gender, Cardiac Dysfunction and Sepsis
PLOS ONE | www.plosone.org 8 June 2014 | Volume 9 | Issue 6 | e100631
Akt activation in cardiomyocytes was reduced in ovariectomized
rats [33]. In addition, activation of the PI3K/Akt signalling
cascade by estrogen was observed in rat cardiomyocytes [29]. A
few studies have been conducted to explain the exact mechanism
by which estrogen induces Akt activation. Estrogen receptor a has
been shown to bind with the p85 a regulatory subunit of PI3K in a
ligand-dependent manner in human endothelial cells; increased
estrogen receptor associated PI3K activity induced by estrogen
leads to the activation of Akt and eNOS in human endothelial cells
[34]. Another study has shown that the direct interaction between
estrogen receptor and the PI3K regulatory subunit p85 in a time-
dependent manner was consistent with the temporal profile for Akt
phosphorylation in neurons [35]. Additionally, in cardiomyocytes,
estrogen stimulated Akt activation and prevented DNA fragmen-
tation [29]. Thus, we propose that the higher cardiac activation of
Akt in female mice importantly contributes to the improvement in
cardiac dysfunction in sepsis.
Activation of Akt is known to modulate eNOS activity through
phosphorylation of eNOS at Ser1177 [36,37]. Indeed, the present
study reported an increase in eNOS phosphorylation in female
than in male hearts, which was correlated with the expression
pattern of Akt. Augmentation of eNOS activity was shown to
decrease sepsis-related increases in neutrophil-endothelial cell
interaction and potentially maintain microvascular patency in
sepsis [38]. There is good evidence that estrogen modulates
activation of eNOS. Estrogen receptor a has been implicated in
increased PI3K/Akt and eNOS activation induced by estrogen in
human endothelial cells [34]. Another study demonstrated that
estrogen stimulation of the eNOS promoter was mediated via
increased activity of the transcription factor Sp1 (which is essential
for the activity of the human eNOS promoter) [39]. Moreover,
estradiol treatment in guinea pigs increased eNOS mRNA in
skeletal muscle, suggesting an increase in eNOS activity [40]. In
line with these findings, data from the present study indicate that
less vulnerability of female hearts to sepsis may be mediated in part
by an increased activity of eNOS, secondary to the activation of
PI3K/Akt pathway.
NF-kB controls the transcription of a large number of genes,
particularly those involved in inflammatory and acute stress
responses, such as cytokines, chemokines, cell adhesion molecules,
apoptotic factors, and other mediators [41]. IkBa inactivates NF-
kB by masking the nuclear localization signals of the NF-kB
proteins and by sequestering NF-kB as an inactive complex in the
cytoplasm [41,42]. Phosphorylation of IkBa by IkB kinase (IKK)
leads to the dissociation of IkBa from NF-kB, which liberates NF-
kB to enter the nucleus and activates the expression of NF-kB
target genes [41]. Up-regulation of NF-kB has been linked to the
development of myocardial dysfunction following the onset of
sepsis [19,43]. Inhibition of NF-kB activation results in improved
myocardial function after septic challenge [18]. Additionally, the
dimer of estrogen and its receptor can bind to NF-kB in osteoblasts
following IL-1b exposure, further, NF-kB is proved to be one of
the targets for estrogen receptor, resulting in reduced IL-6
promoter activity [44]. In murine splenic macrophages, estradiol
inhibited TNF-a and IL-6 production was associated with a
decreased LPS-induced NF-kB-binding activity [44]. Thus, our
present results indicate that less myocardial dysfunction in females
subjected to LPS/PepG could be importantly due to the decreased
activation of NF-kB (secondary to the reduced activation of IkBa
and, hence, nuclear translocation) in murine hearts. Activation of
NF-kB may also mediate myocardial dysfunction through
induction of expression of its target gene iNOS, which plays an
important role in sepsis-related hypotension and impaired left
ventricular function [45,46]. Indeed, in the present study, iNOS
expression was increased in male hearts, which correlates with
their exacerbated cardiac dysfunction under septic insult.
In addition to causing the expression of iNOS, NF-kB activation
also leads to a pronounced increase in production of inflammatory
mediators such as TNF-a and IL-6 [47]. In turn, TNF also
activates NF-kB through TNF-receptor-associated factors, this
increases cytokine production, thus forming a feed-forward
mechanism and amplifying the inflammatory reaction [48]. There
is good evidence that those inflammatory cytokines play a
significant role in the pathogenesis of sepsis-induced cardiac
dysfunction [49,50]. Moreover, clinical studies showed that
stimulation of healthy females with LPS or LTA led to lower
TNF-a and IL-6 levels in blood than males [10]. Female patients
with sepsis had a higher survival rate, which was correlated with
lower TNF-a and higher IL-10 levels [9], while male trauma-
patients showed higher IL-6 level than females [11]. In exper-
imental studies, cardiomyocyte TNF-a and IL-6 release was
markedly lower in female than male rats following burn injury
[23]. In addition, female hearts expressed less myocardial TNF-a
in isolated hearts subjected to ischemia/reperfusion injury [21] or
LPS treatment [51]. Others have suggested that elevated plasma
TNF-a and IL-6 induced by trauma-hemorrhage was prevented
by estradiol treatment in rats [24,52]. Consistent with these
findings, in our study, female mice, which had better cardiac
function following septic insult, expressed less myocardial TNF-a
and IL-6 than male mice subjected to LPS/PepG co-administra-
tion.
Our study demonstrated that the gender dimorphism of cardiac
dysfunction in response to septic insults was abolished by the
severe injury induced by high dose of LPS (9 mg/kg)/PepG
(1 mg/kg) co-administration. This is in line with a report that the
inflammatory cytokine response differed more strongly between
blood from men and women after low-concentration of LPS
stimulation compared with a higher stimulus concentration [10].
Population-based studies on sex dimorphism in mortality after
sepsis showed inconsistent results. Some studies reported increased
mortality in males [7,8], while other studies demonstrated
mortality from severe sepsis/sepsis was not affected by gender
[53,54]. The inconsistency may have resulted from multiple
factors such as pre-existing co-morbidities. More importantly, our
observations of gender dimorphism in cardiac dysfunction
responses to different severities of injury may partially explain
the conflicting clinical data.
It could be argued that the present study did not provide
information about proestrus/estrus or diestrus state of estrus cycle
in female mice subjected to septic insults. In this regard, a recent
study showed that female mice with CLP survived better than
male mice that underwent CLP, but the higher survival in females
did not correspond to any specific estrus phase [55]. Furthermore,
it has been demonstrated vaginal cytology does not reflect changes
of circulating estrogens in females and that the estrus cycle cannot
be predicted by vaginal smears [56]. Moreover, we did not notice
a lot of variations in data obtained from female mice in our study.
Therefore, estrus cycle phases were not monitored in this study.
Conclusion
Our findings provide for the first time a very clear indication of
a gender dimorphism in the sepsis-induced cardiac dysfunction
in vivo and we have shown that female mice have less cardiac
dysfunction than male mice subjected to either co-administration
of LPS/PepG in young mice or CLP in older mice. We report here
that female hearts subjected to sepsis have a greater activation of
Akt/eNOS, and less activation of NF-kB, which in turn results in
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reduced expression of the proinflammaroy cytokines TNF-a and
IL-6 as well as iNOS. We propose that the above pro-survival and
anti-inflammatory signalling events contribute to the reduced
cardiac dysfunction in female mice with sepsis.
Author Contributions
Conceived and designed the experiments: CT NSAP JC. Performed the
experiments: JC FC MC SMC. Analyzed the data: JC CT NSAP FC MC
SMC. Contributed to the writing of the manuscript: JC CT NSAP SMC
MC.
References
1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001)
Epidemiology of severe sepsis in the United States: analysis of incidence,
outcome, and associated costs of care. Crit Care Med 29:1303–1310.
2. Padkin A, Goldfrad C, Brady AR, Young D, Black N, et al. (2003) Epidemiology
of severe sepsis occurring in the first 24 hrs in intensive care units in England,
Wales, and Northern Ireland. Crit Care Med 31:2332–2338.
3. Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a
novel understanding of the disorder and a new therapeutic approach. Lancet
Infect Dis 13:260–268.
4. Fernandes CJ Jr, Akamine N, Knobel E (1999) Cardiac troponin: a new serum
marker of myocardial injury in sepsis. Intensive Care Med 25:1165–1168.
5. Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, et al. (2008)
Incidence, organ dysfunction and mortality in severe sepsis: a Spanish
multicentre study. Crit Care 12: R158.
6. Bone RC (1992) Toward an epidemiology and natural history of SIRS (systemic
inflammatory response syndrome). JAMA 268:3452–3455.
7. Ghuman AK, Newth CJ, Khemani RG (2013) Impact of gender on sepsis
mortality and severity of illness for prepubertal and postpubertal children.
J Pediatr 163:835–840 e831.
8. Melamed A, Sorvillo FJ (2009) The burden of sepsis-associated mortality in the
United States from 1999 to 2005: an analysis of multiple-cause-of-death data.
Crit Care 13: R28.
9. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F (1998) Gender
differences in human sepsis. Arch Surg 133:1200–1205.
10. Aulock SV, Deininger S, Draing C, Gueinzius K, Dehus O, et al. (2006) Gender
difference in cytokine secretion on immune stimulation with LPS and LTA.
J Interferon Cytokine Res 26:887–892.
11. Oberholzer A, Keel M, Zellweger R, Steckholzer U, Trentz O, et al. (2000)
Incidence of septic complications and multiple organ failure in severely injured
patients is sex specific. J Trauma 48:932–937.
12. Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, et al. (1997)
Females in proestrus state maintain splenic immune functions and tolerate sepsis
better than males. Crit Care Med 25:106–110.
13. Sener G, Arbak S, Kurtaran P, Gedik N, Yegen BC (2005) Estrogen protects the
liver and intestines against sepsis-induced injury in rats. J Surg Res 128:70–78.
14. Angele MK, Wichmann MW, Ayala A, Cioffi WG, Chaudry IH (1997)
Testosterone receptor blockade after hemorrhage in males. Restoration of the
depressed immune functions and improved survival following subsequent sepsis.
Arch Surg 132:1207–1214.
15. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving
bioscience research reporting: the ARRIVE guidelines for reporting animal
research. PLoS Biol 8: e1000412.
16. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL
(2010) Guidelines for reporting experiments involving animals: the ARRIVE
guidelines. Br J Pharmacol 160:1573–1576.
17. Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock–a review
of laboratory models and a proposal. J Surg Res 29:189–201.
18. Coldewey SM, Rogazzo M, Collino M, Patel NS, Thiemermann C (2013)
Inhibition of IkappaB kinase reduces the multiple organ dysfunction caused by
sepsis in the mouse. Dis Model Mech 6:1031–1042.
19. Khan AI, Coldewey SM, Patel NS, Rogazzo M, Collino M, et al. (2013)
Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via
activation of the beta-common receptor. Dis Model Mech 6:1021–1030.
20. Collino M, Pini A, Mugelli N, Mastroianni R, Bani D, et al. (2013) Beneficial
effect of prolonged heme oxygenase 1 activation in a rat model of chronic heart
failure. Dis Model Mech 6:1012–1020.
21. Wang M, Baker L, Tsai BM, Meldrum KK, Meldrum DR (2005) Sex
differences in the myocardial inflammatory response to ischemia-reperfusion
injury. Am J Physiol Endocrinol Metab 288: E321–326.
22. Szalay L, Shimizu T, Suzuki T, Yu HP, Choudhry MA, et al. (2006) Estradiol
improves cardiac and hepatic function after trauma-hemorrhage: role of
enhanced heat shock protein expression. American journal of physiology
Regulatory, integrative and comparative physiology 290: R812–818.
23. Horton JW, White DJ, Maass DL (2004) Gender-related differences in
myocardial inflammatory and contractile responses to major burn trauma.
Am J Physiol Heart Circ Physiol 286: H202–213.
24. Hsu JT, Kan WH, Hsieh CH, Choudhry MA, Bland KI, et al. (2009)
Mechanism of salutary effects of estrogen on cardiac function following trauma-
hemorrhage: Akt-dependent HO-1 up-regulation. Crit Care Med 37:2338–
2344.
25. Kim YD, Chen B, Beauregard J, Kouretas P, Thomas G, et al. (1996) 17 beta-
Estradiol prevents dysfunction of canine coronary endothelium and myocardium
and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation
94:2901–2908.
26. Kolodgie FD, Farb A, Litovsky SH, Narula J, Jeffers LA, et al. (1997)
Myocardial protection of contractile function after global ischemia by
physiologic estrogen replacement in the ovariectomized rat. J Mol Cell Cardiol
29:2403–2414.
27. Nelson JF, Felicio LS, Randall PK, Sims C, Finch CE (1982) A longitudinal
study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length
and vaginal cytology. Biol Reprod 27:327–339.
28. Rajesh KG, Suzuki R, Maeda H, Yamamoto M, Yutong X, et al. (2005)
Hydrophilic bile salt ursodeoxycholic acid protects myocardium against
reperfusion injury in a PI3K/Akt dependent pathway. J Mol Cell Cardiol
39:766–776.
29. Yu HP, Hsieh YC, Suzuki T, Choudhry MA, Schwacha MG, et al. (2007) The
PI3K/Akt pathway mediates the nongenomic cardioprotective effects of
estrogen following trauma-hemorrhage. Ann Surg 245:971–977.
30. Bae S, Zhang L (2005) Gender differences in cardioprotection against ischemia/
reperfusion injury in adult rat hearts: focus on Akt and protein kinase C
signaling. J Pharmacol Exp Ther 315:1125–1135.
31. Liu CJ, Lo JF, Kuo CH, Chu CH, Chen LM, et al. (2009) Akt mediates 17beta-
estradiol and/or estrogen receptor-alpha inhibition of LPS-induced tumor
necresis factor-alpha expression and myocardial cell apoptosis by suppressing the
JNK1/2-NFkappaB pathway. J Cell Mol Med 13:3655–3667.
32. Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KD, et al. (2001)
Myocardial Akt activation and gender: increased nuclear activity in females
versus males. Circ Res 88:1020–1027.
33. Ren J, Hintz KK, Roughead ZK, Duan J, Colligan PB, et al. (2003) Impact of
estrogen replacement on ventricular myocyte contractile function and protein
kinase B/Akt activation. Am J Physiol Heart Circ Physiol 284: H1800–1807.
34. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, et al. (2000)
Interaction of oestrogen receptor with the regulatory subunit of phosphatidy-
linositol-3-OH kinase. Nature 407:538–541.
35. Mannella P, Brinton RD (2006) Estrogen receptor protein interaction with
phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and
extracellular signal-regulated kinase 1/2 in the same population of cortical
neurons: a unified mechanism of estrogen action. J Neurosci 26:9439–9447.
36. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, et al. (1999)
Activation of nitric oxide synthase in endothelial cells by Akt-dependent
phosphorylation. Nature 399:601–605.
37. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, et al. (1999) Regulation
of endothelium-derived nitric oxide production by the protein kinase Akt.
Nature 399:597–601.
38. Khan R, Kirschenbaum LA, LaRow C, Berna G, Griffin K, et al. (2010)
Augmentation of platelet and endothelial cell eNOS activity decreases sepsis-
related neutrophil-endothelial cell interactions. Shock 33:242–246.
39. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, et al. (1998)
Estrogens increase transcription of the human endothelial NO synthase gene:
analysis of the transcription factors involved. Hypertension 31:582–588.
40. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, et al. (1994)
Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc
Natl Acad Sci U S A 91:5212–5216.
41. Senftleben U, Karin M (2002) The IKK/NF-kappa B pathway. Crit Care Med
30: S18–26.
42. Jacobs MD, Harrison SC (1998) Structure of an IkappaBalpha/NF-kappaB
complex. Cell 95:749–758.
43. Kapoor A, Shintani Y, Collino M, Osuchowski MF, Busch D, et al. (2010)
Protective role of peroxisome proliferator-activated receptor-beta/delta in septic
shock. Am J Respir Crit Care Med 182:1506–1515.
44. Stein B, Yang MX (1995) Repression of the interleukin-6 promoter by estrogen
receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 15:4971–
4979.
45. Barth E, Radermacher P, Thiemermann C, Weber S, Georgieff M, et al. (2006)
Role of inducible nitric oxide synthase in the reduced responsiveness of the
myocardium to catecholamines in a hyperdynamic, murine model of septic
shock. Crit Care Med 34:307–313.
46. Thiemermann C, Vane J (1990) Inhibition of nitric oxide synthesis reduces the
hypotension induced by bacterial lipopolysaccharides in the rat in vivo.
Eur J Pharmacol 182:591–595.
47. Brown MA, Jones WK (2004) NF-kappaB action in sepsis: the innate immune
system and the heart. Front Biosci 9:1201–1217.
48. Miyamoto S, Verma IM (1995) Rel/NF-kappa B/I kappa B story. Adv Cancer
Res 66:255–292.
49. Natanson C, Eichenholz PW, Danner RL, Eichacker PQ, Hoffman WD, et al.
(1989) Endotoxin and tumor necrosis factor challenges in dogs simulate the
cardiovascular profile of human septic shock. J Exp Med 169:823–832.
Gender, Cardiac Dysfunction and Sepsis
PLOS ONE | www.plosone.org 10 June 2014 | Volume 9 | Issue 6 | e100631
50. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, et al. (1985) A
circulating myocardial depressant substance in humans with septic shock. Septic
shock patients with a reduced ejection fraction have a circulating factor that
depresses in vitro myocardial cell performance. J Clin Invest 76:1539–1553.
51. Zhu H, Shan L, Peng T (2009) Rac1 mediates sex difference in cardiac tumor
necrosis factor-alpha expression via NADPH oxidase-ERK1/2/p38 MAPK
pathway in endotoxemia. J Mol Cell Cardiol 47:264–274.
52. Hsieh YC, Frink M, Hsieh CH, Choudhry MA, Schwacha MG, et al. (2007)
Downregulation of migration inhibitory factor is critical for estrogen-mediated
attenuation of lung tissue damage following trauma-hemorrhage. Am J Physiol
Lung Cell Mol Physiol 292: L1227–1232.
53. Mahmood K, Eldeirawi K, Wahidi MM (2012) Association of gender with
outcomes in critically ill patients. Crit Care 16: R92.
54. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW (2000) Incidence and
mortality of severe sepsis in surgical intensive care patients: the influence of
patient gender on disease process and outcome. Intensive Care Med 26:167–
172.
55. Drechsler S, Weixelbaumer K, Raeven P, Jafarmadar M, Khadem A, et al.
(2012) Relationship between age/gender-induced survival changes and the
magnitude of inflammatory activation and organ dysfunction in post-traumatic
sepsis. PLoS One 7: e51457.
56. Weixelbaumer KM, Drechsler S, Wehrenpfennig P, Khadem A, Bahrami S, et
al. (2014) Estrus cycle status defined by vaginal cytology does not correspond to
fluctuations of circulating estrogens in female mice. Shock 41:145–153.
Gender, Cardiac Dysfunction and Sepsis
PLOS ONE | www.plosone.org 11 June 2014 | Volume 9 | Issue 6 | e100631
